Exane BNP Paribas Initiates Coverage On Keurig Dr Pepper with Neutral Rating, Announces Price Target of $36
Portfolio Pulse from Benzinga Newsdesk
Exane BNP Paribas has initiated coverage on Keurig Dr Pepper (NASDAQ:KDP) with a Neutral rating and a price target of $36.
June 24, 2024 | 10:39 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Exane BNP Paribas has initiated coverage on Keurig Dr Pepper with a Neutral rating and a price target of $36.
The Neutral rating suggests that the analyst does not expect significant upside or downside in the short term. The price target of $36 provides a benchmark for investors, but the neutral stance indicates limited immediate impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100